• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性膜抗原PET成像及免疫组化在腺样囊性癌中的初步分析

Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.

作者信息

Klein Nulent Thomas J W, van Es Robert J J, Krijger Gerard C, de Bree Remco, Willems Stefan M, de Keizer Bart

机构信息

Department of Head and Neck Surgical Oncology, Utrecht Cancer Center, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, Utrecht, 3508 GA, The Netherlands.

Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1614-1621. doi: 10.1007/s00259-017-3737-x. Epub 2017 Jun 7.

DOI:10.1007/s00259-017-3737-x
PMID:28593386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5537328/
Abstract

BACKGROUND

Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour of the secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis of 9 AdCC patients was conducted to analyse the visualization of AdCC on PSMA PET/CT and to investigate the expression of PSMA on primary, recurrent and metastatic AdCC tumour tissue using immunohistochemistry.

RESULTS

Local recurrence occurred in six patients and eight developed distant metastasis. All PET/CTs depicted PSMA-ligand uptake. Four PSMA PET/CTs showed suspected residual disease, eight scans depicted uptake in areas suspected of distant metastasis. Median Maximum Standardized Uptake Value (SUV) in local recurrent and distant metastatic AdCC was 2.52 (IQR 2.41-5.95) and 4.01 (IQR 2.66-8.71), respectively. All primary tumours showed PSMA expression on immunohistochemistry (5-90% expression), as well as all available specimens of local recurrence and distant metastases.

CONCLUSION

PSMA PET/CT is able to detect and visualize local recurrent and distant metastatic AdCC. PSMA-specific targeting is supported by PSMA expression on immunohistochemistry.

摘要

背景

头颈部腺样囊性癌(AdCC)是一种罕见的分泌腺恶性上皮肿瘤。许多患者会出现生长缓慢的局部复发和/或远处转移,而针对这些情况的治疗选择有限。对9例AdCC患者进行了回顾性分析,以分析AdCC在PSMA PET/CT上的显影情况,并使用免疫组织化学研究PSMA在原发性、复发性和转移性AdCC肿瘤组织中的表达。

结果

6例患者出现局部复发,8例发生远处转移。所有PET/CT均显示PSMA配体摄取。4例PSMA PET/CT显示可疑残留病灶,8次扫描显示在怀疑远处转移的区域有摄取。局部复发和远处转移的AdCC的最大标准化摄取值(SUV)中位数分别为2.52(四分位间距2.41 - 5.95)和4.01(四分位间距2.66 - 8.71)。所有原发性肿瘤在免疫组织化学上均显示PSMA表达(表达率5 - 90%),局部复发和远处转移的所有可用标本也均如此。

结论

PSMA PET/CT能够检测并显影局部复发和远处转移的AdCC。免疫组织化学上PSMA的表达支持PSMA特异性靶向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa0/5537328/bc918e687e82/259_2017_3737_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa0/5537328/f9af21f2c622/259_2017_3737_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa0/5537328/bc918e687e82/259_2017_3737_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa0/5537328/f9af21f2c622/259_2017_3737_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fa0/5537328/bc918e687e82/259_2017_3737_Fig2_HTML.jpg

相似文献

1
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.前列腺特异性膜抗原PET成像及免疫组化在腺样囊性癌中的初步分析
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1614-1621. doi: 10.1007/s00259-017-3737-x. Epub 2017 Jun 7.
2
Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study.镓-PSMA-HBED-CC PET/CT 成像在腺样囊性癌和唾液腺癌中的应用:一项 2 期影像学研究。
Theranostics. 2020 Jan 12;10(5):2273-2283. doi: 10.7150/thno.38501. eCollection 2020.
3
Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.头颈部腺样囊性癌中前列腺特异性膜抗原(PSMA)的表达。
BMC Cancer. 2020 Jun 5;20(1):519. doi: 10.1186/s12885-020-06847-9.
4
Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study.镥-177-PSMA 治疗复发性/转移性唾液腺癌:一项前瞻性试点研究。
Theranostics. 2024 Aug 26;14(14):5388-5399. doi: 10.7150/thno.99035. eCollection 2024.
5
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
6
Comparison of 68Ga-PSMA-HBED-CC and 18F-FDG PET/CT in the Evaluation of Adenoid Cystic Carcinoma-A Prospective Study.68Ga-PSMA-HBED-CC 与 18F-FDG PET/CT 在腺样囊性癌评估中的比较——一项前瞻性研究。
Clin Nucl Med. 2023 Nov 1;48(11):e509-e515. doi: 10.1097/RLU.0000000000004868.
7
Is there a nonnegligible effect of maximum standardized uptake value in the staging and management of prostate cancer with 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography imaging? A single-center experience.68Ga-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像在前列腺癌分期和管理中,最大标准化摄取值是否有不可忽视的影响?一项单中心经验。
J Cancer Res Ther. 2021 Oct-Dec;17(6):1351-1357. doi: 10.4103/jcrt.JCRT_1223_20.
8
Utility of Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma.镓前列腺特异性膜抗原正电子发射断层扫描在复发性肾细胞癌诊断及疗效评估中的应用价值
J Med Imaging Radiat Oncol. 2017 Jun;61(3):372-378. doi: 10.1111/1754-9485.12590. Epub 2017 Jan 24.
9
Correlations of the Ga-PSMA PET/CT derived primary prostate tumor PSMA expression parameters and metastatic patterns in patients with Gleason Score >7 prostate cancer.Ga-PSMA PET/CT 衍生的原发性前列腺肿瘤 PSMA 表达参数与 Gleason 评分>7 前列腺癌患者转移模式的相关性。
Hell J Nucl Med. 2020 May-Aug;23(2):120-124. doi: 10.1967/s002449912100. Epub 2020 Jul 27.
10
Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.PSMA配体在PET/CT上于头颈部唾液腺和浆液黏液腺中的生理分布。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 May;125(5):478-486. doi: 10.1016/j.oooo.2018.01.011. Epub 2018 Jan 31.

引用本文的文献

1
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma.一项关于腺样囊性癌患者的PSMA靶向F-18-DCFPyL PET成像的初步研究。
Sci Rep. 2025 May 16;15(1):17104. doi: 10.1038/s41598-025-01515-z.
2
Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.肾细胞癌中的诊疗一体化——迈向新机遇还是死胡同——一项系统评价
Pharmaceuticals (Basel). 2024 Dec 19;17(12):1721. doi: 10.3390/ph17121721.
3
Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study.

本文引用的文献

1
Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma.转移性腺样囊性癌的镓-前列腺特异性膜抗原正电子发射断层扫描-计算机断层扫描成像
Nucl Med Mol Imaging. 2017 Dec;51(4):360-361. doi: 10.1007/s13139-016-0445-6. Epub 2016 Aug 16.
2
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding.转移性去势抵抗性前列腺癌的靶向 α 治疗:Ac-PSMA-617 的剂量估算和经验剂量探索。
J Nucl Med. 2017 Oct;58(10):1624-1631. doi: 10.2967/jnumed.117.191395. Epub 2017 Apr 13.
3
PSMA Uptake in Mediastinal Sarcoidosis.
镥-177-PSMA 治疗复发性/转移性唾液腺癌:一项前瞻性试点研究。
Theranostics. 2024 Aug 26;14(14):5388-5399. doi: 10.7150/thno.99035. eCollection 2024.
4
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication.个性化 PET 成像在肿瘤学中的应用:对荟萃分析的伞式综述,以指导合适的放射性药物选择和适应证。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):208-224. doi: 10.1007/s00259-024-06882-9. Epub 2024 Sep 11.
5
The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic Review.前列腺特异性膜抗原(PSMA)靶向正电子发射断层扫描(PET)在唾液腺恶性肿瘤中的潜在作用:一项最新的系统评价
Diagnostics (Basel). 2024 Jul 14;14(14):1516. doi: 10.3390/diagnostics14141516.
6
The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors.唾液腺肿瘤中前列腺特异性膜抗原表达的重要性
Turk Arch Otorhinolaryngol. 2022 Dec;60(4):206-211. doi: 10.4274/tao.2022.2022-12-3. Epub 2023 Jul 7.
7
The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now?唾液腺癌的治疗现状——我们现在在哪里?
Int J Mol Sci. 2022 Nov 28;23(23):14891. doi: 10.3390/ijms232314891.
8
PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?前列腺以外实体瘤中的前列腺特异性膜抗原(PSMA)表达:是否已准备好用于诊疗应用?
J Clin Med. 2022 Nov 7;11(21):6590. doi: 10.3390/jcm11216590.
9
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study.PSMA 导向的唾液腺肿瘤成像与治疗:单中心回顾性研究。
J Nucl Med. 2023 Mar;64(3):372-378. doi: 10.2967/jnumed.122.264342. Epub 2022 Sep 22.
10
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?前列腺特异性膜抗原放射性配体摄取作为实体肿瘤新生血管生成的生物标志物:诊断还是治疗诊断因素?
Cancers (Basel). 2022 Aug 21;14(16):4039. doi: 10.3390/cancers14164039.
纵隔结节病中的 PSMA 摄取。
Clin Nucl Med. 2017 Apr;42(4):303-305. doi: 10.1097/RLU.0000000000001543.
4
Subcutaneous Lobular Capillary Hemangioma on 68Ga-PSMA PET/CT.68Ga-PSMA PET/CT 显像皮下小叶状毛细血管瘤。
Clin Nucl Med. 2017 Apr;42(4):e214-e215. doi: 10.1097/RLU.0000000000001542.
5
Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST.PSMA在高级别肉瘤(包括滑膜肉瘤、横纹肌肉瘤、未分化肉瘤和恶性外周神经鞘膜瘤)肿瘤新生血管中的表达。
Oncotarget. 2017 Jan 17;8(3):4268-4276. doi: 10.18632/oncotarget.13994.
6
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.68Ga PSMA-11 PET/CT 脑肿瘤成像的诊断价值——初步分析。
Clin Nucl Med. 2017 Jan;42(1):e41-e48. doi: 10.1097/RLU.0000000000001451.
7
Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients.乳腺癌患者的镓-PSMA-HBED-CC正电子发射断层显像
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):689-694. doi: 10.1007/s00259-016-3563-6. Epub 2016 Nov 8.
8
Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.头颈部转移性腺样囊性癌生存模式的差异。
Head Neck. 2017 Mar;39(3):456-463. doi: 10.1002/hed.24613. Epub 2016 Oct 24.
9
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.德国多中心研究:177镥-PSMA-617放射性配体疗法用于晚期前列腺癌患者的研究
J Nucl Med. 2017 Jan;58(1):85-90. doi: 10.2967/jnumed.116.183194. Epub 2016 Oct 20.
10
Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.胰腺浆液性囊腺瘤在 68Ga PSMA PET/CT 上摄取。
Clin Nucl Med. 2017 Jan;42(1):56-57. doi: 10.1097/RLU.0000000000001423.